Patent details

EP2897980 Title: KIR3DL2 BINDING AGENTS

Basic Information

Publication number:
EP2897980
PCT Application Number:
EP2013069302
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137657037
PCT Publication Number:
WO2014044686
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
KIR3DL2 BINDING AGENTS
French Title of Invention:
AGENTS DE LIAISON DE KIR3DL2
German Title of Invention:
KIR3DL2-BINDEMITTEL
SPC Number:

Dates

Filing date:
17/09/2013
Grant date:
06/11/2019
EP Publication Date:
29/07/2015
PCT Publication Date:
27/03/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/11/2019
EP B1 Publication Date:
06/11/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/09/2020
Expiration date:
17/09/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/10/2019
 
 

Name:
Innate Pharma
Address:
117, Avenue de Luminy, 13009 Marseille, France (FR)

Inventor

1

Name:
GAUTHIER, Laurent
Address:
France (FR)

2

Name:
SICARD, Hélène
Address:
France (FR)

3

Name:
ROSSI, Benjamin
Address:
France (FR)

4

Name:
ZERBIB, Stéphanie
Address:
France (FR)

5

Name:
KOLLNBERGER, Simon
Address:
United Kingdom (GB)

6

Name:
PATUREL, Carine
Address:
France (FR)

7

Name:
CORNEN, Stéphanie
Address:
France (FR)

Priority

Priority Number:
201261702834 P
Priority Date:
19/09/2012
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; G01N 33/569;

Publication

European Patent Bulletin

Issue number:
201945
Publication date:
06/11/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages